jrnls.org logo
Submit

BROWSE ALL JOURNALS

Type 2 letters to search all 19 journals

SEE ALL 19 JOURNALS
Pharmacognosy MagazineNOW IN
Article

The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model

2,3★, 3, 4,5, 4,5, 4,5, 3,4★ Corresponding author

  1. 1Departments of, University, 830011 Urumqi, Xinjiang People’s Republic of China.
  2. 2Drug Analysis.
  3. 3Traditional Uighur Medicine and.
  4. 4Pharmacology, Xinjiang Medical University, 830011 Urumqi, Xinjiang People’s Republic of China.
  5. 5Department of Pharmacology, University Victor Segalen Bordeaux 2, 33076 Bordeaux, France.

CORRESPONDENCE

Ainiwaer Aikemu

Drug Analysis.

Received: 15-08-2011; Revised: 28-09-2011.

Volume 8, Issue 30 · pp. 141–148 · 2012 · DOI: 10.4103/0973-1296.96568

View on PM original site ↗

ABSTRACT

Aim: This study was designed to study the antitumor and antioxidant activity of Uighur medicine abnormal savda munziq (ASMq) in the S180 and Ehrlich ascites carcinoma mice tumor model.Materials and Methods: The serum levels of superoxide dismutase (SOD), malonaldehyde (MDA), and glutathione-catalase (GSH-PX) were analyzed, and the mice were also subjected to a hypoxia tolerance test. Their climbing ability was also analyzed.Results: The findings of the study revealed that ASMq-treatment leads to an increase in blood serum SOD and GSH-PX levels but a decrease in blood serum MDA levels. Moreover, ASMq-treatment enhanced the survival time of mice maintained under hypoxic conditions and improved their mice climbing ability.Conclusions: The results of this study indicate that ASMq has obvious antitumor and antioxidative effects.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Aikemu, A., Yusup, A., Umar, A., Berké, B., Moore, N., & Upur, H. (2012). The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model. Pharmacognosy Magazine, 8(30), 141–148. https://doi.org/10.4103/0973-1296.96568